Skip to main content
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 1, 2013

Articles

Preface
pp. i-i(1)
Author: Hadjipavlou-Litina, D.

Favourites:
ADD

Editorial (Hot Topic: Therapeutic Targets in Neurodegenerative Diseases)
pp. 1-2(2)
Authors: Kim, Jungsu; L. Eriksen, Jason

Favourites:
ADD
Favourites:
ADD

Diverse Functions of γ-secretase: Releasing Signaling Fragments and Deleterious Molecules
pp. 15-27(13)
Authors: Han, Sun-Ho; Kim, Chaeyoung; Mook-Jung, Inhee

Favourites:
ADD

Defects in RNA Metabolism links FTD and ALS Pathogenesis: TDP-43, FUS, and C9orf72
pp. 28-40(13)
Authors: Deng, Qiudong; Chalermpalanupap, Termpanit; Kukar, Thomas

Favourites:
ADD

Reconstructing the Hsp90/Tau Machine
pp. 41-45(5)
Authors: K. Jinwal, Umesh; Koren III, John; A. Dickey, Chad

Favourites:
ADD
Favourites:
ADD

Role of Autophagy in Alzheimer's Disease
pp. 55-66(12)
Authors: Kim, Jaekwang; Yoon, Hyejin; Kim, Jungsu

Favourites:
ADD

Trisubstituted Phenolic Compounds as Inhibitors of Acetylcholinesterase and Amyloid Beta Aggregate Formation
pp. 67-74(8)
Authors: M. Peckels, Caroline; S. Alexander, Nathan; N. Wilson, Gina; M. Karty, Joel; M. Matera, Kathryn

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content